XML 38 R24.htm IDEA: XBRL DOCUMENT v3.23.2
INCOME TAXES (Tables)
12 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets
        
   YEAR ENDED MARCH 31, 
   2023   2022 
Deferred tax assets:          

Research and development credit carryforwards

  $3,442,000   $3,442,000 

Capitalized research and development costs

   519,000     
Net operating loss carryforwards(1)   24,158,000    22,039,000 
Stock compensation   1,903,000    1,609,000 
Total deferred tax assets   30,022,000    27,090,000 
           
Total deferred tax liabilities        
           
Net deferred tax assets   30,022,000    27,090,000 
Valuation allowance for deferred tax assets   (30,022,000)   (27,090,000)
           
Net deferred tax assets  $   $ 
Provision for income taxes
        
   2023   2022 
         
Income taxes (benefit) at federal statutory rate of 21.00%  $(2,526,000)  $(2,188,000)
Tax effect on non-deductible expenses and credits   2,000    1,000 
True up items   57,000    (5,000)
Expiration of net operating loss carryforwards (1)   353,000    593,000 
Change in valuation allowance   2,114,000    1,599,000 
Income Tax Expense (Benefit)  $   $ 

 ______________

(1) Pursuant to Internal Revenue Code Section 382, use of our tax net operating loss carryforwards may be limited.